Cargando…
Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
PURPOSE: Distal cholangiocarcinoma and pancreatic ductal adenocarcinoma are malignancies with poor prognoses that can be difficult to distinguish preoperatively. Thrombospondin-2 has been proposed as a novel diagnostic biomarker for early pancreatic ductal adenocarcinoma. The aim of the present stud...
Autores principales: | Byrling, J., Hilmersson, K. S., Ansari, D., Andersson, R., Andersson, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794913/ https://www.ncbi.nlm.nih.gov/pubmed/34319497 http://dx.doi.org/10.1007/s12094-021-02685-8 |
Ejemplares similares
-
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
por: Byrling, Johannes, et al.
Publicado: (2020) -
Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
por: Byrling, Johannes, et al.
Publicado: (2017) -
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019) -
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018) -
Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
por: Kriz, D., et al.
Publicado: (2020)